Add comment on:Arizona State Senator Blocks Funding for Long-Sought Medical Marijuana Research
After 22 years of hard-fought efforts, the non-profit pharmaceutical company Multidisciplinary Association for Psychedelic Studies (MAPS) has finally obtained approval from the U.S. Department of Health and Human Services (HHS) for a FDA clinical trial to examine the medical safety and efficacy of marijuana. The trial would study military veterans suffering from treatment-resistant post-traumatic stress disorder (PTSD). Yet the study’s ability to receive Arizona state funding is in jeopardy due to State Senator Kimberly Yee.
Guidelines for commenting on news articles:
Thanks for contributing to Indybay's open publishing newswire. You may use any format for your response article, from traditional academic discourse to subjective personal account. Please keep it on topic and concise. And please read our editorial policy, privacy, and legal statements before continuing. Or go back to the article.